Your Top 100 most-cited badge

A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.

The article

518O Overall survival results from ARIEL4: A phase III study assessing rucaparib vs chemotherapy in patients with advanced, relapsed ovarian carcinoma and a deleterious BRCA1/2 mutation

A.M. Oza, A.S. Lisyanskaya, А. А. Феденко, A.C. de Melo, Y. Shparik, Igor Bondarenko and 13 more

Rank
97 of 3,616
Percentile
top 2.7%
Where
Annals of Oncology, 2022
Citations
39

From the 2022 list, OpenAlex counts as of 2026-10-29.

Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.